MAPT and Alzheimer disease: Furthermore, plasma levels of neuroprostanes—biomarkers of LPO—correlate strongly with medial temporal lobe atrophy in early-stage AD (82), while elevated isoprostane concentrations in cerebrospinal fluid are closely associated with tau pathology (83).